ABOUT ELITE
Overview
Our Facility
Management & Key Employees
Our Board
Careers
PRODUCTS
PIPELINE
Generic
Branded
TECHNOLOGY
Technology Overview
How It Works
One Bead System
Two Bead System
INVESTOR RELATIONS
Press Releases
Events & Presentations
SEC Filings
Shareholder Meeting
Governance Documents
Investor Contacts
Email Alerts
HOME
|
CAREERS
|
CONTACT
|
NEWS
|
Skip to content
About Elite
Overview
Management & Key Employees
Our Board
Careers
Products
Pipeline
Generic
Branded
Technology
Technology Overview
How It Works
One Bead System
Two Bead System
Investor Relations
Press Releases
Events & Presentations
SEC Filings
Shareholder Meeting
Governance Documents
Investor Contacts
Email Alerts
Investor Relations
Press Releases
Events &Presentations
SEC Filings
ShareholderMeeting
GovernanceDocuments
Investor Contacts
Email Alerts
Press Releases
Select:
Show All
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Archived
Mar 11, 2019
Elite Pharmaceuticals Enters into Strategic Marketing Alliance with Lannett For Generic Adderall®
Feb 11, 2019
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2019 Ended December 31, 2018 and Provides Conference Call Information
Feb 07, 2019
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2019 Financial Results on February 12, 2019
Jan 03, 2019
Elite Pharmaceuticals and SunGen Pharma File ANDA for an Antibiotic
Dec 10, 2018
Elite Pharmaceuticals and SunGen Pharma Receive FDA Approval for Generic Adderall®
Nov 09, 2018
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2019 Ended September 30, 2018 and Provides Conference Call Information
Nov 07, 2018
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2019 Financial Results on November 12, 2018
Nov 05, 2018
Elite Pharmaceuticals Launches Generic Methadone Tablets
Oct 23, 2018
Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
Aug 14, 2018
Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
3
4
5
6
7
8
9
10
11
12
13
<<
<
>
>>
Back to top
Privacy